Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA PANACEA BIOTECH ASTRAZENECA PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 91.1 0.7 12,157.4% View Chart
P/BV x 16.5 1.0 1,625.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
PANACEA BIOTECH
Mar-22
ASTRAZENECA PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs4,580454 1,009.5%   
Low Rs2,529148 1,708.8%   
Sales per share (Unadj.) Rs322.2108.0 298.5%  
Earnings per share (Unadj.) Rs24.6176.0 14.0%  
Cash flow per share (Unadj.) Rs31.4183.1 17.2%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %0.30-  
Book value per share (Unadj.) Rs203.8138.6 147.0%  
Shares outstanding (eoy) m25.0061.25 40.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.02.8 395.8%   
Avg P/E ratio x144.31.7 8,438.3%  
P/CF ratio (eoy) x113.11.6 6,885.5%  
Price / Book Value ratio x17.42.2 803.5%  
Dividend payout %40.60-   
Avg Mkt Cap Rs m88,86318,427 482.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3021,829 125.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,0566,612 121.8%  
Other income Rs m148110 134.6%   
Total revenues Rs m8,2046,722 122.0%   
Gross profit Rs m86216,623 5.2%  
Depreciation Rs m170437 38.8%   
Interest Rs m101,808 0.5%   
Profit before tax Rs m83014,488 5.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2143,709 5.8%   
Profit after tax Rs m61610,779 5.7%  
Gross profit margin %10.7251.4 4.3%  
Effective tax rate %25.825.6 100.9%   
Net profit margin %7.6163.0 4.7%  
BALANCE SHEET DATA
Current assets Rs m7,65310,406 73.5%   
Current liabilities Rs m3,9238,028 48.9%   
Net working cap to sales %46.336.0 128.8%  
Current ratio x2.01.3 150.5%  
Inventory Days Days6161 100.7%  
Debtors Days Days3973 53.5%  
Net fixed assets Rs m2,1207,118 29.8%   
Share capital Rs m5061 81.6%   
"Free" reserves Rs m5,0448,427 59.9%   
Net worth Rs m5,0948,488 60.0%   
Long term debt Rs m0341 0.0%   
Total assets Rs m9,77317,523 55.8%  
Interest coverage x88.49.0 981.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 218.4%   
Return on assets %6.471.8 8.9%  
Return on equity %12.1127.0 9.5%  
Return on capital %16.5184.6 8.9%  
Exports to sales %018.2 0.0%   
Imports to sales %31.722.4 141.1%   
Exports (fob) Rs mNA1,205 0.0%   
Imports (cif) Rs m2,5521,484 171.9%   
Fx inflow Rs m4421,236 35.8%   
Fx outflow Rs m2,5521,735 147.1%   
Net fx Rs m-2,110-499 422.5%   
CASH FLOW
From Operations Rs m1,008-1,084 -93.0%  
From Investments Rs m4712,826 0.4%  
From Financial Activity Rs m-95-11,759 0.8%  
Net Cashflow Rs m961-17 -5,557.0%  

Share Holding

Indian Promoters % 0.0 73.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 0.4 886.0%  
FIIs % 2.5 0.1 1,778.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 26.4 94.7%  
Shareholders   49,085 49,078 100.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Panacea Biotech Share Price Performance

Period ASTRAZENECA PHARMA Panacea Biotech S&P BSE HEALTHCARE
1-Day -0.02% 2.74% 0.23%
1-Month 2.02% -3.17% 0.36%
1-Year 3.02% -33.85% -6.87%
3-Year CAGR 7.94% 3.73% 20.16%
5-Year CAGR 24.01% -12.89% 11.07%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.